Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationMOHTY, M; BOIRON, J. M; TABRIZI, R et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 1, pp 77-84, issn 0268-3369, 8 p.Article

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationMOHTY, M; DE LAVALLADE, H; BLAISE, D et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 6, pp 527-530, issn 0268-3369, 4 p.Article

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenMOHTY, M; JACOT, W; STOPPA, A. M et al.Leukemia. 2003, Vol 17, Num 11, pp 2168-2177, issn 0887-6924, 10 p.Article

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphomaCROCCHIOLO, R; CASTAGNA, L; BALZAROTTI, M et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, pp 249-252, issn 0268-3369, 4 p.Article

Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia : results of the GRAALL AFR09 studyDELANNOY, A; DELABESSE, E; TURLURE, P et al.Leukemia. 2006, Vol 20, Num 9, pp 1526-1532, issn 0887-6924, 7 p.Article

Traitement précoce de l'anémie, en cours de chimiothérapie, par érythropoïétine : qu'attendre d'un schéma simplifié ? À propos de l'expérience de l'Institut Paoli Calmettes-Marseille = Early treatment of anemia in patients undergoing chemotherapy, with erythropoietin: what is to be expected from a simplified regimen. About the experience at the Institut Paoli Calmettes-MarseilleBRAUD, A.-C; GRAVIS, G; SCHIANO, J.-M et al.Oncologie (Paris). 2004, Vol 6, Num 1, pp 49-53, issn 1292-3818, 5 p.Article

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomasCASTAGNA, L; BRAMANTI, S; BALZAROTTI, M et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 12, pp 1475-1480, issn 0268-3369, 6 p.Article

A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaCOSO, D; SEBBAN, C; IVANOV, V et al.Bone marrow transplantation (Basingstoke). 2006, Vol 38, Num 3, pp 217-222, issn 0268-3369, 6 p.Article

A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patientsBOUABDALLAH, R; LEFRERE, F; VARET, B et al.Leukemia. 1999, Vol 13, Num 10, pp 1491-1496, issn 0887-6924Article

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTCASTAGNA, L; BOUBDALLAH, R; CALMELS, B et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 6, pp 794-798, issn 0268-3369, 5 p.Article

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myelomaDE LAVALLADE, H; EL-CHEIKHL, J; MOHTY, M et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 11, pp 953-960, issn 0268-3369, 8 p.Article

Safety and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis : a report on 15 patientsBOUABDALLAH, R; COSO, D; GONZAGUE-CASABIANCA, L et al.Leukemia research. 2000, Vol 24, Num 6, pp 491-495, issn 0145-2126Article

Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma : an oligocentric report on 42 patientsBOUABDALLAH, R; STOPPA, A.-M; ALZIEU, C et al.Leukemia. 1999, Vol 13, Num 6, pp 950-956, issn 0887-6924Article

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donorsCASTAGNA, L; CROCCHIOLO, R; CHARBONNIER, A et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 9, pp 1246-1247, issn 0268-3369, 2 p.Article

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCTEL-CHEIKH, J; VENTON, G; DURAN, S et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 11, pp 1472-1477, issn 0268-3369, 6 p.Article

Prise en charge actuelle de la leucémie lymphoïde chronique = Chronic lymphocytic leukaemia : Current managementAURRAN-SCHLEINITZ, T; ARNOULET, C; IVANOV, V et al.La Revue de médecine interne (Paris). 2008, Vol 29, Num 5, pp 424-435, issn 0248-8663, 12 p.Article

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia : a donor vs no donor comparisonMOHTY, M; DE LAVALLADE, H; LADAIQUE, P et al.Leukemia. 2005, Vol 19, Num 6, pp 916-920, issn 0887-6924, 5 p.Article

Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-hodgkin's lymphoma : a retrospective series on 126 patients from a single centerBOUABDALLAH, R; COSO, D; COSTELLO, R et al.Bone marrow transplantation (Basingstoke). 2000, Vol 25, Num 1, pp 35-40, issn 0268-3369Article

Lymphomes B primitifs du médiastin: aspect clinique = Primary mediastinal B-cell lymphomaCOSO, D; REY, J; BOUABDALLAH, R et al.Revue de pneumologie clinique (Paris). 2010, Vol 66, Num 1, pp 32-35, issn 0761-8417, 4 p.Article

Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phaseMALOISEL, F; GUERCI, A; ABGRALL, J. F et al.Leukemia. 2002, Vol 16, Num 4, pp 573-580, issn 0887-6924Article

Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3) : Final analysis of survival in two consecutive ISC trialsBOUABDALLAH, R; STOPPA, A. M; COSO, D et al.Annals of oncology. 2001, Vol 12, Num 4, pp 513-517, issn 0923-7534Article

A cyclophosphamide-induced autoimmune diabetesATLAN-GEPNER, C; BOUABDALLAH, R; VALERO, R et al.Lancet (British edition). 1998, Vol 352, Num 9125, pp 373-374, issn 0140-6736Article

Phlébite récidivante par déficit combiné en protéine C et S chez un sidéen = Recurrent venous thrombosis due to combined protein C and S deficiency in an AIDS patientMALATERRE, H. R; COSO, D; DAVER, L et al.La Semaine des hôpitaux de Paris. 1996, Vol 72, Num 9-10, pp 279-280, issn 0037-1777Article